| # | Drug | Count |
|---|---|---|
| 0 | ADAPALENE | 2826 |
| 1 | SALICYLIC ACID | 884 |
| 2 | DUPILUMAB | 608 |
| 3 | TIRZEPATIDE | 260 |
| 4 | ERGOCALCIFEROL | 244 |
| 5 | CABOZANTINIB | 229 |
| 6 | ACETAMINOPHEN | 216 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 180 |
| 8 | PREDNISONE | 168 |
| 9 | OMEPRAZOLE MAGNESIUM | 143 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVOBENZONE, OCTISALATE, AND OCTOCRYLENE | 23 | 0.0230 |
| 1 | BENZOYL PEROXIDE | 127 | 0.0189 |
| 2 | SALICYLIC ACID | 884 | 0.0168 |
| 3 | ADAPALENE | 2826 | 0.0156 |
| 4 | SULFUR | 85 | 0.0101 |
| 5 | ERGOCALCIFEROL | 244 | 0.0082 |
| 6 | INFLIXIMAB-DYYB | 28 | 0.0081 |
| 7 | CABOZANTINIB | 229 | 0.0047 |
| 8 | RIPRETINIB | 21 | 0.0040 |
| 9 | HUMAN IMMUNOGLOBULIN G | 67 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 2859 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 608 |
| 2 | GLP-1 Receptor Agonist [EPC] | 424 |
| 3 | Corticosteroid [EPC] | 417 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 363 |
| 5 | Kinase Inhibitor [EPC] | 284 |
| 6 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 260 |
| 7 | Provitamin D2 Compound [EPC] | 244 |
| 8 | Vitamin C [EPC] | 196 |
| 9 | Proton Pump Inhibitor [EPC] | 178 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Retinoid [EPC] | 2859 | 0.0116 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 22 | 0.0106 |
| 3 | Provitamin D2 Compound [EPC] | 244 | 0.0082 |
| 4 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 5 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 23 | 0.0039 |
| 7 | Interleukin-13 Antagonist [EPC] | 25 | 0.0037 |
| 8 | Human Immunoglobulin G [EPC] | 75 | 0.0036 |
| 9 | Neurokinin 3 Receptor Antagonist [EPC] | 8 | 0.0035 |